SG43126A1 - Method of treating immunoinlammatory disease - Google Patents

Method of treating immunoinlammatory disease

Info

Publication number: SG43126A1
Authority: SG; Singapore
Prior art keywords: treating; medicament; immunoinlammatory; disease; pref
Prior art date: 1991-09-17

Application number

SG1996004061A

Other languages

English (en)

Inventor

Craig Eugene Caufield

John Henry Musser

Surendra Nath Sehgal

Original Assignee

American Home Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-09-17

Filing date

1992-09-15

Publication date

1997-10-17

1992-09-15 Application filed by American Home Prod filed Critical American Home Prod

1997-10-17 Publication of SG43126A1 publication Critical patent/SG43126A1/en

Links

201000010099 disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
239000003814 drug Substances 0.000 abstract 3
229930105110 Cyclosporin A Natural products 0.000 abstract 1
PMATZTZNYRCHOR-CGLBZJNRSA-N Cyclosporin A Chemical compound CC[C@@H]1NC(=O)[C@H]([C@H](O)[C@H](C)C\C=C\C)N(C)C(=O)[C@H](C(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](CC(C)C)N(C)C(=O)[C@@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)N(C)C(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)N(C)C(=O)CN(C)C1=O PMATZTZNYRCHOR-CGLBZJNRSA-N 0.000 abstract 1
108010036949 Cyclosporine Proteins 0.000 abstract 1
241000124008 Mammalia Species 0.000 abstract 1
229960001265 ciclosporin Drugs 0.000 abstract 1
239000002552 dosage form Substances 0.000 abstract 1
230000000495 immunoinflammatory effect Effects 0.000 abstract 1
ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 abstract 1
229960002930 sirolimus Drugs 0.000 abstract 1
QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 abstract 1
230000000699 topical effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicinal Preparation (AREA)

SG1996004061A 1991-09-17 1992-09-15 Method of treating immunoinlammatory disease SG43126A1 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US76112091A	1991-09-17	1991-09-17

Publications (1)

Publication Number	Publication Date
SG43126A1 true SG43126A1 (en)	1997-10-17

Family

ID=25061205

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SG1996004061A SG43126A1 (en)	1991-09-17	1992-09-15	Method of treating immunoinlammatory disease

Country Status (23)

Country	Link
US (1)	US5286730A (cs)
EP (1)	EP0533433B1 (cs)
JP (1)	JP2810599B2 (cs)
KR (1)	KR100299394B1 (cs)
AT (1)	ATE151289T1 (cs)
AU (1)	AU659868B2 (cs)
CA (1)	CA2078379C (cs)
CZ (1)	CZ281900B6 (cs)
DE (1)	DE69218864T2 (cs)
DK (1)	DK0533433T3 (cs)
ES (1)	ES2100297T3 (cs)
GR (1)	GR3023680T3 (cs)
HK (1)	HK108697A (cs)
HU (1)	HU211112B (cs)
IL (3)	IL117640A (cs)
MX (1)	MX9205202A (cs)
NZ (2)	NZ328124A (cs)
PH (1)	PH30270A (cs)
SG (1)	SG43126A1 (cs)
SK (1)	SK279521B6 (cs)
TW (1)	TW212759B (cs)
UA (1)	UA27742C2 (cs)
ZA (1)	ZA927010B (cs)

Families Citing this family (68)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5286731A (en) *	1991-09-17	1994-02-15	American Home Products Corporation	Method of treating immunoinflammatory bowel disease
JP2741285B2 (ja) *	1992-05-22	1998-04-15	千寿製薬株式会社	緑内障治療剤
US5434260A (en) *	1992-10-13	1995-07-18	American Home Products Corporation	Carbamates of rapamycin
US5489680A (en) *	1992-10-13	1996-02-06	American Home Products Corporation	Carbamates of rapamycin
US5480989A (en) *	1992-10-13	1996-01-02	American Home Products Corporation	Carbamates of rapamycin
US5480988A (en) *	1992-10-13	1996-01-02	American Home Products Corporation	Carbamates of rapamycin
CH686761A5 (de) *	1993-05-27	1996-06-28	Sandoz Ag	Galenische Formulierungen.
AT408520B (de) *	1993-05-27	2001-12-27	Novartis Erfind Verwalt Gmbh	Galenische formulierungen
DE4329503A1 (de) *	1993-09-01	1995-03-02	Galenik Labor Freiburg Gmbh	Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
US6204243B1 (en)	1993-09-01	2001-03-20	Novatis Ag	Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis
US5527907A (en) *	1993-11-19	1996-06-18	Abbott Laboratories	Macrolide immunomodulators
WO1995014023A1 (en) *	1993-11-19	1995-05-26	Abbott Laboratories	Semisynthetic analogs of rapamycin (macrolides) being immunomodulators
US5389639A (en) *	1993-12-29	1995-02-14	American Home Products Company	Amino alkanoic esters of rapamycin
US5525610A (en) *	1994-03-31	1996-06-11	American Home Products Corporation	42-Epi-rapamycin and pharmaceutical compositions thereof
US5362718A (en) *	1994-04-18	1994-11-08	American Home Products Corporation	Rapamycin hydroxyesters
US5463048A (en) *	1994-06-14	1995-10-31	American Home Products Corporation	Rapamycin amidino carbamates
WO1996006847A1 (en) *	1994-08-31	1996-03-07	Pfizer Inc.	Process for preparing demethylrapamycins
US5561138A (en) *	1994-12-13	1996-10-01	American Home Products Corporation	Method of treating anemia
US5496832A (en) *	1995-03-09	1996-03-05	American Home Products Corporation	Method of treating cardiac inflammatory disease
BE1009856A5 (fr)	1995-07-14	1997-10-07	Sandoz Sa	Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule.
US5912224A (en) *	1996-02-22	1999-06-15	The General Hospital Corporation	Methods and compositions for enhancing cellular response to TGF-β ligands
EP1208847B8 (en) *	1996-07-30	2007-02-14	Novartis AG	Pharmaceutical compositions for the treatment of transplant rejection, as well as autoimmune or inflammatory conditions
CA2270373A1 (en) *	1996-10-31	1998-05-07	American Home Products Corporation	Synergistic composition comprising rapamycin and calcitriol
DE19844397A1 (de) *	1998-09-28	2000-03-30	Hilti Ag	Abrasive Schneidkörper enthaltend Diamantpartikel und Verfahren zur Herstellung der Schneidkörper
US6670355B2 (en) *	2000-06-16	2003-12-30	Wyeth	Method of treating cardiovascular disease
EP1319008B1 (en)	2000-09-19	2008-10-15	Wyeth	Water soluble rapamycin esters
US6399625B1 (en)	2000-09-27	2002-06-04	Wyeth	1-oxorapamycins
US6399626B1 (en)	2000-10-02	2002-06-04	Wyeth	Hydroxyesters of 7-desmethylrapamycin
US6440991B1 (en)	2000-10-02	2002-08-27	Wyeth	Ethers of 7-desmethlrapamycin
US20040018228A1 (en) *	2000-11-06	2004-01-29	Afmedica, Inc.	Compositions and methods for reducing scar tissue formation
TWI286074B (en)	2000-11-15	2007-09-01	Wyeth Corp	Pharmaceutical composition containing CCI-779 as an antineoplastic agent
KR20020050135A (ko) *	2000-12-20	2002-06-26	조명재	피부 주름 예방 및 완화를 목적으로 하는 피부 외용 조성물
TWI296196B (en) *	2001-04-06	2008-05-01	Wyeth Corp	Antineoplastic combinations
TWI233359B (en) *	2001-04-06	2005-06-01	Wyeth Corp	Pharmaceutical composition for treating neoplasm
ZA200603888B (en) *	2001-06-01	2007-05-30	Wyeth Corp	Antineoplastic combinations
UA77200C2 (en)	2001-08-07	2006-11-15	Wyeth Corp	Antineoplastic combination of cci-779 and bkb-569
BR0211986A (pt)	2001-08-22	2004-09-28	Wyeth Corp	29-enóis de rapamicina
MXPA04001523A (es)	2001-08-22	2004-05-31	Wyeth Corp	Dialdehidos de rapamicina.
US6641611B2 (en) *	2001-11-26	2003-11-04	Swaminathan Jayaraman	Therapeutic coating for an intravascular implant
JP4547911B2 (ja)	2002-02-01	2010-09-22	アリアド・ファーマシューティカルズ・インコーポレイテッド	リン含有化合物およびその用途
NZ537829A (en)	2002-07-30	2006-09-29	Wyeth Corp	Parenteral formulations containing a rapamycin hydroxyester
EP1389480A1 (en) *	2002-08-14	2004-02-18	Mondobiotech Interferon SA	Therapeutical use of guanylhydrazones for the inhibition of CD83 dependent processes and dendritic cell maturation
DE60324609D1 (de) *	2002-09-17	2008-12-18	Wyeth Corp	GRANULIERTE FORMULIERUNG DES RAPAMYCINESTERS CCl-779
AR042938A1 (es) *	2003-02-06	2005-07-06	Wyeth Corp	Uso del cci-779 en el tratamiento de la fibrosis hepatica
UA83484C2 (uk) *	2003-03-05	2008-07-25	Уайт	Спосіб лікування раку грудей комбінацією похідного рапаміцину і інгібітора ароматази - летрозолу, фармацевтична композиція
ATE352301T1 (de) *	2003-04-22	2007-02-15	Wyeth Corp	Antineoplastische zusammensetzungen
US20050059583A1 (en)	2003-09-15	2005-03-17	Allergan, Inc.	Methods of providing therapeutic effects using cyclosporin components
WO2005048927A2 (en) *	2003-11-13	2005-06-02	Combinatorx, Incorporated	Methods and reagents for the treatment of inflammatory disorders
WO2006115509A2 (en)	2004-06-24	2006-11-02	Novartis Vaccines And Diagnostics Inc.	Small molecule immunopotentiators and assays for their detection
US7135455B2 (en) *	2004-11-15	2006-11-14	Allergan, Inc	Methods for the therapeutic use of cyclosporine components
US7151085B2 (en) *	2004-11-15	2006-12-19	Allergan, Inc.	Therapeutic methods using cyclosporine components
CA2629714A1 (en)	2005-11-14	2007-05-24	Ariad Gene Therapeutics, Inc.	Administration of an mtor inhibitor to treat patients with cancer
WO2008022256A2 (en) *	2006-08-16	2008-02-21	Blagosklonny Mikhail V	Methods and compositions for preventing or treating age-related diseases
RU2316005C1 (ru) *	2006-09-07	2008-01-27	Государственное учреждение Московский областной научно-исследовательский клинический институт им. М.Ф. Владимирского (МОНИКИ им. М.Ф. Владимирского)	Способ оценки эффективности лечения пузырчатки
EP2083834B1 (en)	2006-09-13	2017-06-21	Elixir Medical Corporation	Macrocyclic lactone compounds and methods for their use
CA2668645A1 (en) *	2006-11-07	2008-05-15	Alcon Research, Ltd.	Method of treating asthma, allergic rhinitis, and skin disorders
US9205080B2 (en) *	2006-11-16	2015-12-08	Transderm, Inc.	Methods of treating keratin hyperproliferation disorders using mTOR inhibitors
EP2352459A4 (en) *	2008-10-03	2013-09-25	Elixir Medical Corp	MACROCYCLIC LACTON COMPOUNDS AND METHOD FOR THEIR USE
AU2010233073B2 (en)	2009-04-10	2014-07-31	Haiyan Qi	Novel anti-aging agents and methods to identify them
WO2014117035A1 (en)	2013-01-24	2014-07-31	Transderm, Inc.	COMPOSITIONS FOR TRANSDERMAL DELIVERY OF mTOR INHIBITORS
EP3057601A4 (en) *	2013-10-14	2017-06-21	Izun Pharmaceuticals Corp.	Methods for treatment of m-tor inhibitor-associated stomatitis
HUP1400075A2 (hu)	2014-02-14	2015-08-28	Druggability Technologies Ip Holdco Jersey Ltd	Sirolimus és származékainak komplexei, elõállítása és gyógyszerészeti kompozíciói
US20160184279A1 (en) *	2014-12-10	2016-06-30	Transderm, Inc.	METHODS OF TREATING PAIN AND/OR ITCH WITH SMALL MOLECULE INHIBITORS TARGETING AN mTOR PATHWAY
KR20180081501A (ko)	2015-09-24	2018-07-16	드렉셀유니버시티	진피 장애를 치료하거나 예방하는 신규한 조성물 및 방법
JP7108631B2 (ja)	2017-01-06	2022-07-28	パルヴェラセラピューティクス、インク．	ｍＴＯＲ阻害剤の無水組成物およびその使用方法
US10456383B2 (en) *	2017-06-01	2019-10-29	The Board Of Trustees Of The Leland Stanford Junior University	Targeted approach in the management of Epidermolysis bullosa
US11000513B2 (en)	2018-07-02	2021-05-11	Palvella Therapeutics, Inc.	Anhydrous compositions of mTOR inhibitors and methods of use
WO2020047342A1 (en) *	2018-08-30	2020-03-05	Chemistryrx	Sirolimus containing compositions

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ZA737247B (en) *	1972-09-29	1975-04-30	Ayerst Mckenna & Harrison	Rapamycin and process of preparation
US4023264A (en) *	1976-06-21	1977-05-17	Littelfuse, Inc.	Method of making miniature plug-in fuses of different fuse ratings
PH26083A (en) *	1987-11-09	1992-02-06	Sandoz Ltd	11, 28-dioxa-4-azatricyclo [22.3.1.04.9) octacos-18-ene derivatives and pharmaceutical compositions containing them and method of use thereof
US4996193A (en) *	1989-03-03	1991-02-26	The Regents Of The University Of California	Combined topical and systemic method of administration of cyclosporine
US5023263A (en) *	1990-08-09	1991-06-11	American Home Products Corporation	42-oxorapamycin
EP0542860B1 (en) *	1990-08-10	1998-05-20	AnorMED Inc	Immunosuppressive compositions
US5023262A (en) *	1990-08-14	1991-06-11	American Home Products Corporation	Hydrogenated rapamycin derivatives
US5078999A (en) *	1991-02-22	1992-01-07	American Home Products Corporation	Method of treating systemic lupus erythematosus
US5080899A (en) *	1991-02-22	1992-01-14	American Home Products Corporation	Method of treating pulmonary inflammation

1992
- 1992-08-17 US US07/931,242 patent/US5286730A/en not_active Expired - Lifetime
- 1992-09-09 SK SK2785-92A patent/SK279521B6/sk unknown
- 1992-09-09 CZ CS922785A patent/CZ281900B6/cs not_active IP Right Cessation
- 1992-09-11 MX MX9205202A patent/MX9205202A/es not_active IP Right Cessation
- 1992-09-14 JP JP4244549A patent/JP2810599B2/ja not_active Expired - Fee Related
- 1992-09-14 ZA ZA927010A patent/ZA927010B/xx unknown
- 1992-09-15 EP EP92308384A patent/EP0533433B1/en not_active Expired - Lifetime
- 1992-09-15 DK DK92308384.4T patent/DK0533433T3/da active
- 1992-09-15 AT AT92308384T patent/ATE151289T1/de not_active IP Right Cessation
- 1992-09-15 SG SG1996004061A patent/SG43126A1/en unknown
- 1992-09-15 ES ES92308384T patent/ES2100297T3/es not_active Expired - Lifetime
- 1992-09-15 DE DE69218864T patent/DE69218864T2/de not_active Expired - Fee Related
- 1992-09-15 NZ NZ328124A patent/NZ328124A/xx unknown
- 1992-09-15 NZ NZ244340A patent/NZ244340A/xx unknown
- 1992-09-16 HU HU9202955A patent/HU211112B/hu not_active IP Right Cessation
- 1992-09-16 PH PH44946A patent/PH30270A/en unknown
- 1992-09-16 IL IL11764092A patent/IL117640A/xx not_active IP Right Cessation
- 1992-09-16 AU AU24507/92A patent/AU659868B2/en not_active Ceased
- 1992-09-16 KR KR1019920016795A patent/KR100299394B1/ko not_active Expired - Fee Related
- 1992-09-16 CA CA002078379A patent/CA2078379C/en not_active Expired - Fee Related
- 1992-09-16 IL IL10318992A patent/IL103189A/en not_active IP Right Cessation
- 1992-10-02 TW TW081107842A patent/TW212759B/zh active
1993
- 1993-06-15 UA UA93002912A patent/UA27742C2/uk unknown
1996
- 1996-03-25 IL IL11764096A patent/IL117640A0/xx unknown
1997
- 1997-06-04 GR GR970401324T patent/GR3023680T3/el unknown
- 1997-06-26 HK HK108697A patent/HK108697A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
ZA927010B (en)	1994-03-14
HK108697A (en)	1997-08-22
GR3023680T3 (en)	1997-09-30
UA27742C2 (uk)	2000-10-16
KR100299394B1 (ko)	2001-10-22
JP2810599B2 (ja)	1998-10-15
EP0533433A1 (en)	1993-03-24
US5286730A (en)	1994-02-15
AU659868B2 (en)	1995-06-01
DE69218864T2 (de)	1997-07-17
IL103189A0 (en)	1993-02-21
MX9205202A (es)	1993-03-01
PH30270A (en)	1997-02-20
HU211112B (en)	1995-10-30
AU2450792A (en)	1993-03-18
DK0533433T3 (da)	1997-05-12
IL103189A (en)	1996-08-04
HUT64846A (en)	1994-03-28
CZ278592A3 (en)	1993-04-14
IL117640A (en)	1999-08-17
CA2078379C (en)	2003-07-29
IL117640A0 (en)	1996-07-23
DE69218864D1 (de)	1997-05-15
SK279521B6 (sk)	1998-12-02
CA2078379A1 (en)	1993-03-18
NZ328124A (en)	2000-01-28
HU9202955D0 (en)	1992-12-28
NZ244340A (en)	1999-06-29
CZ281900B6 (cs)	1997-03-12
ES2100297T3 (es)	1997-06-16
ATE151289T1 (de)	1997-04-15
EP0533433B1 (en)	1997-04-09
JPH05194529A (ja)	1993-08-03
SK278592A3 (en)	1995-03-08
TW212759B (cs)	1993-09-11

Publication	Publication Date	Title
PH30270A (en)	1997-02-20	Method of treating immunoinflammatory disease
EP0345302A4 (en)	1990-02-20	LIPOSOMIC VESICLES FOR THE INTRAPERITONEAL ADMINISTRATION OF THERAPEUTIC AGENTS.
ES2173111T3 (es)	2002-10-16	Uso de fenserina para la preparacion de medicamentos para el tratamiento de desordenes cognoscitivos.
IE893840L (en)	1990-06-01	Use of acetyl d-carnitines for treating glaucoma
GR3034186T3 (en)	2000-11-30	3,4-diarylchromans for treatment of dermatitis
LT97135A (en)	1997-12-29	Use of melatonin in the manufacture of a medicament for treating patients suffering from drug addiction
PL342099A1 (en)	2001-05-21	Therapeutic agents
LV11728A (lv)	1997-04-20	Farmaceitiska kompozicija
IT1293583B1 (it)	1999-03-08	Uso dell'acido gammaidrossibutirrico per il trattamento delle sindromi demenziali
USD435109S (en)	2000-12-12	Therapeutic treatment device
MD1716C2 (ro)	2002-02-28	Utilizare a melatoninei pentru tratamentul pacienţilor dependenţi de benzodiazepine
NO990450L (no)	1999-01-29	Behandling av sinnslidelser
NZ307601A (en)	2000-04-28	Use of a pharmaceutically acceptable oxalate derivative in the manufacture of a medicament for the treatment of skin conditions
EP0286802A3 (en)	1992-01-08	Use of ofloxacin in treating or preventing locally periodontal disease
ZA96260B (en)	1996-08-01	A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidenyl)-isoxazole or one of its pharmaceutically acceptable salts
EP0389570A4 (en)	1991-01-09	High integrity liposomes and method of preration and use
AU4250697A (en)	1998-03-19	Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection
IL128494A0 (en)	2000-01-31	Use of inhibitors of pkc for the manufacture of a medicament for the treatment of central nervous system diseases associated with hiv infection
HUP0004647A3 (en)	2002-01-28	Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
WO1996029076A3 (en)	1997-02-13	Treatment of inflammatory bowel disorders with cotinine
MX9800365A (es)	1998-03-29	Tratamiento de leucemia aguda con interleucina-10.
KR920009403A (ko)	1992-06-25	수면장해 치료용 이미다조벤조디아제핀
AU4391196A (en)	1996-07-31	A transdermal therapeutic system for the administration of (s)-3-methyl-5-(1-methyl-2-pyrrolidinyl)-isoxazole or one of its pharmaceutically acceptable salts
SI0829262T1 (en)	2002-06-30	Use of PKC inhibitors for the manufacture of a medicament for the treatment of sexual dysfunctions
IL128493A0 (en)	2000-01-31	Use of pkc inhibitors for the manufacture of a medicament for the treatment of htlv-1 infections